A scientist and a financier walk into a bar… It sounds like the setup to a joke, but in the case of molecular biologist […]
Genentech documentary celebrates 50th anniversary of biotech Read More »
The Tigerlily Foundation was born from a promise made in a moment of profound vulnerability. In 2006, Maimah Karmo was a 32-year-old mother to
Tigerlily Foundation joining conversation at PACE Read More »
One afternoon in 2024, the BIO Federal Government Affairs team received a call from Hill staff who said, “We just met the most amazing
In Rare Trials Summit keynote, BIO expert highlights lives touched by PPRV Read More »
Continuing confusion about compliance is exacerbating the harms that new pharmaceutical tariffs cause the biotech industry, especially small innovative firms, experts say. Tariffs of
Tariffs’ drag on innovation compounded by lack of guidance, experts say Read More »
Research Triangle Park resurgent with billions in investment in biotechnology manufacturing. With a famous biotech cluster in Research Triangle Park (RTP) established almost 70
BIO on the American Road visits pioneering NC biotech hub Read More »
It’s been a long day at the university lab, but the researchers, who have been working on a niche bit of molecular biology research,
Bayh-Dole Act’s benefits include $3 trillion in U.S. output, report finds Read More »
BIO 2026 Start-Up Stadium winner generates human data to improve clinical translation. Artificial intelligence is opening new possibilities for drug discovery. But in neuroscience,
BrainStorm Therapeutics combines brain organoids and AI for CNS drug discovery Read More »
The BIO 2026 Start-up Stadium winner targets a rare disease. As Herb Sarnoff sits in the hospital, waiting for a pain specialist to see
iNFixion seeks NF1 treatment by enhancing what the body is doing right Read More »
For decades, Congress has passed legislation to protect Americans from public health emergencies, ranging from national security threats to disease outbreaks and natural disasters,
A national security priority: BIO pushes PAHPA reauthorization in 2026 Read More »
With tariffs on patented pharmaceuticals and input materials set to take effect for all companies on Sept. 29, the lack of clarity about rules
With pharmaceutical tariffs looming, guidance on compliance is still lacking Read More »
